Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1959 1
1961 7
1962 5
1963 5
1964 10
1965 4
1966 8
1967 10
1968 10
1969 10
1970 15
1971 24
1972 22
1973 19
1974 42
1975 33
1976 26
1977 28
1978 40
1979 34
1980 31
1981 47
1982 53
1983 74
1984 77
1985 85
1986 103
1987 99
1988 86
1989 111
1990 129
1991 108
1992 121
1993 92
1994 108
1995 113
1996 128
1997 138
1998 166
1999 143
2000 165
2001 190
2002 173
2003 166
2004 179
2005 207
2006 179
2007 180
2008 192
2009 197
2010 194
2011 220
2012 229
2013 241
2014 241
2015 236
2016 228
2017 244
2018 271
2019 288
2020 280
2021 354
2022 351
2023 353
2024 347
2025 370
2026 92

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,040 results

Results by year

Filters applied: . Clear all
Page 1
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.
Shitara K, Shah MA, Lordick F, Van Cutsem E, Ilson DH, Klempner SJ, Kang YK, Lonardi S, Hung YP, Yamaguchi K, Enzinger P, Nakajima T, Matsangou M, Cao Y, Li R, Moran D, Pophale R, Oh M, Ranganath R, Ajani JA, Xu RH. Shitara K, et al. Among authors: yamaguchi k. N Engl J Med. 2024 Sep 26;391(12):1159-1162. doi: 10.1056/NEJMc2409512. Epub 2024 Sep 16. N Engl J Med. 2024. PMID: 39282934 Free PMC article. No abstract available.
HER2-low gastric cancer: is the subgroup targetable?
Shimozaki K, Fukuoka S, Ooki A, Yamaguchi K. Shimozaki K, et al. Among authors: yamaguchi k. ESMO Open. 2024 Sep;9(9):103679. doi: 10.1016/j.esmoop.2024.103679. Epub 2024 Aug 22. ESMO Open. 2024. PMID: 39178538 Free PMC article. Review.
DNA methylation protects cancer cells against senescence.
Chen X, Yamaguchi K, Rodgers B, Goehrig D, Vindrieux D, Lahaye X, Nolot M, Ferry L, Lanciano S, Martin N, Dubus P, Miura F, Ito T, Cristofari G, Manel N, Kanemaki MT, Bernard D, Defossez PA. Chen X, et al. Among authors: yamaguchi k. Nat Commun. 2025 Jul 1;16(1):5901. doi: 10.1038/s41467-025-61157-7. Nat Commun. 2025. PMID: 40595593 Free PMC article.
Placenta-derived factors contribute to human iPSC-liver organoid growth.
Kuse Y, Matsumoto S, Tsuzuki S, Carolina E, Okumura T, Kasai T, Yamabe S, Yamaguchi K, Furukawa Y, Tadokoro T, Ueno Y, Oba T, Tanimizu N, Taniguchi H. Kuse Y, et al. Among authors: yamaguchi k. Nat Commun. 2025 Mar 13;16(1):2493. doi: 10.1038/s41467-025-57551-w. Nat Commun. 2025. PMID: 40082402 Free PMC article.
A pancreatic cancer organoid incorporating macrophages reveals the correlation between the diversity of tumor-associated macrophages and cancer cell survival.
Tabe S, Takeuchi K, Aoshima K, Okumura A, Yamamoto Y, Yanagisawa K, Eto R, Matsuo M, Ueno Y, Konishi T, Furukawa Y, Yamaguchi K, Morinaga S, Miyagi Y, Ohtsuka M, Tanimizu N, Taniguchi H. Tabe S, et al. Among authors: yamaguchi k. Biomaterials. 2025 Mar;314:122838. doi: 10.1016/j.biomaterials.2024.122838. Epub 2024 Sep 18. Biomaterials. 2025. PMID: 39348736 Free article.
Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.
Tanoue K, Ohmura H, Uehara K, Ito M, Yamaguchi K, Tsuchihashi K, Shinohara Y, Lu P, Tamura S, Shimokawa H, Isobe T, Ariyama H, Shibata Y, Tanaka R, Kusaba H, Esaki T, Mitsugi K, Kiyozawa D, Iwasaki T, Yamamoto H, Oda Y, Akashi K, Baba E. Tanoue K, et al. Among authors: yamaguchi k. Nat Commun. 2024 Oct 19;15(1):9033. doi: 10.1038/s41467-024-53262-w. Nat Commun. 2024. PMID: 39426955 Free PMC article.
Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion.
Meguro S, Johmura Y, Wang TW, Kawakami S, Tanimoto S, Omori S, Okamura YT, Hoshi S, Kayama E, Yamaguchi K, Hatakeyama S, Yamazaki S, Shimizu E, Imoto S, Furukawa Y, Kojima Y, Nakanishi M. Meguro S, et al. Among authors: yamaguchi k. Nat Aging. 2024 Nov;4(11):1582-1597. doi: 10.1038/s43587-024-00704-1. Epub 2024 Sep 9. Nat Aging. 2024. PMID: 39251867 Free PMC article.
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.
Siena S, Raghav K, Masuishi T, Yamaguchi K, Nishina T, Elez E, Rodriguez J, Chau I, Di Bartolomeo M, Kawakami H, Suto F, Koga M, Inaki K, Kuwahara Y, Takehara I, Barrios D, Kobayashi K, Grothey A, Yoshino T. Siena S, et al. Among authors: yamaguchi k. Nat Commun. 2024 Nov 25;15(1):10213. doi: 10.1038/s41467-024-53223-3. Nat Commun. 2024. PMID: 39587050 Free PMC article. Clinical Trial.
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization.
Kaito S, Aoyama K, Oshima M, Tsuchiya A, Miyota M, Yamashita M, Koide S, Nakajima-Takagi Y, Kozuka-Hata H, Oyama M, Yogo T, Yabushita T, Ito R, Ueno M, Hirao A, Tohyama K, Li C, Kawabata KC, Yamaguchi K, Furukawa Y, Kosako H, Yoshimi A, Goyama S, Nannya Y, Ogawa S, Agger K, Helin K, Yamazaki S, Koseki H, Doki N, Harada Y, Harada H, Nishiyama A, Nakanishi M, Iwama A. Kaito S, et al. Among authors: yamaguchi k. Nat Commun. 2024 Aug 28;15(1):7359. doi: 10.1038/s41467-024-50498-4. Nat Commun. 2024. PMID: 39198387 Free PMC article.
8,040 results